Nantes University Hospital
OrganisationROR
Trials
Phase 1/2Not yet recruiting202615 people31 Mar 2026clinicaltrials.gov
Phase 3Recruiting2025478 people13 May 2025clinicaltrials.gov
No phaseRecruiting2024830 people3 Sept 2024clinicaltrials.gov
Phase 2Active, not recruiting2024103 people8 Apr 2024clinicaltrials.gov
Phase 3Recruiting2024450 people21 Feb 2024clinicaltrials.gov
Phase 3Completed2021109 people11 Aug 2021clinicaltrials.gov
Phase 2Active, not recruiting202175 people10 Aug 2021clinicaltrials.gov
Phase 4Completed2019419 people9 Jul 2019clinicaltrials.gov
Phase 1Completed201930 people5 Mar 2019clinicaltrials.gov
CollaboratorPhase 2Terminated201926 people25 Sept 2018clinicaltrials.gov
Phase 2Active, not recruiting201950 people31 Jul 2018clinicaltrials.gov
Phase 2/3Terminated201839 people23 Jul 2018clinicaltrials.gov
Phase 2/3Completed201847 people6 Mar 2018clinicaltrials.gov
Phase 3Completed2018217 people22 Nov 2017clinicaltrials.gov
Phase 3Completed201922 people17 Nov 2017clinicaltrials.gov
Phase 3Completed20171,222 people14 Jul 2017clinicaltrials.gov
Phase 3Completed201870 people23 Jun 2017clinicaltrials.gov
Phase 3Withdrawn20160 people21 Sept 2016clinicaltrials.gov
Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant Period
CollaboratorPhase 3Completed201847 people29 Jul 2016clinicaltrials.gov
CollaboratorPhase 3Terminated20162 people2 Oct 2015clinicaltrials.gov